phenethyl isothiocyanate has been researched along with Gallbladder Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Hou, Z; Huang, Q; Li, Q; Mohan, M; Wang, J; Yang, J; Yang, K; Yi, J; Zhan, M; Zhao, B | 1 |
1 other study(ies) available for phenethyl isothiocyanate and Gallbladder Neoplasms
| Article | Year |
|---|---|
Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Cisplatin; Drug Resistance, Neoplasm; Gallbladder Neoplasms; Glutathione; Humans; Isothiocyanates; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Nasturtium; Neoplastic Stem Cells; Xenograft Model Antitumor Assays | 2016 |